skip to main content

Bayesian Basket — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

HardClinical Trials & StatisticsBayesian BasketSCE Medical Oncology

A Bayesian basket trial evaluates the same target across five tumour types. Four small cohorts have similar response rates, but one larger cohort has no responses. What is the central benefit and principal calibration risk of a hierarchical model?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EAdaptive borrowing can improve precision in concordant small cohorts, but excessive shrinkage can create false-positive conclusions in a genuinely inactive heterogeneous cohort

Explanation lettering: C = shown as A · E = shown as B · B = shown as C · A = shown as E

A is correct. B describes complete pooling rather than calibrated hierarchical borrowing; C describes no pooling; D ignores documented type-I-error inflation when borrowing is poorly calibrated; E is false because priors and borrowing rules are core design choices.

Reference: Calibrated Bayesian hierarchical model for basket trials (Clinical Trials 2018): https://pmc.ncbi.nlm.nih.gov/articles/PMC5891374/